90
Participants
Start Date
August 31, 2003
Primary Completion Date
September 30, 2005
Study Completion Date
September 30, 2005
glatiramer acetate 20 mg
glatiramer acetate 20 mg
glatiramer acetate 40 mg
glatiramer acetate 40 mg
MSSM - Corinne Goldsmith Dickinson Center for MS, New York
University of Rochester, Rochester
Allegheny Neurological Associates, Pittsburgh
Geisinger Medical Center, Danville
University of Tennessee, Memphis
Cleveland Clinic Foundation, Cleveland
Indiana University School of Medicine, Indianapolis
Michigan Institute of Neurological Disorders, Farmington Hills
The Minneapolis Clinic of Neurology, LTD, Golden Valley
University of Minnesota, Minneapolis
Consultants in Neurology, Ltd, Northbrook
St. John's Mercy Medical Center, St Louis
VAMC, Salt Lake City
Clinical & Magnetic Resonance Research Ctr., Albuquerque
Center for Neurologic Study, La Jolla
North County Neurology Associates, Oceanside
MS Hub Medical Group, Seattle
Neurology & Neurosurgery, Tacoma
The MS Center of Atlanta, Atlanta
The Maryland Center for M.S., Baltimore
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY